Pulse Operating Margin from 2010 to 2026
| PLSE Stock | USD 23.01 0.39 1.67% |
Check Pulse Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulse Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 1.3 M or Selling General Administrative of 15.8 M, as well as many indicators such as Price To Sales Ratio of 234, Dividend Yield of 0.0 or PTB Ratio of 10.69. Pulse financial statements analysis is a perfect complement when working with Pulse Biosciences Valuation or Volatility modules.
Pulse | Operating Margin | Build AI portfolio with Pulse Stock |
Analyzing Pulse Biosciences's Operating Margin over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Margin has evolved provides context for assessing Pulse Biosciences's current valuation and future prospects.
Latest Pulse Biosciences' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Pulse Biosciences over the last few years. It is Pulse Biosciences' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pulse Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (236.83) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Pulse Operating Margin Regression Statistics
| Arithmetic Mean | (57.51) | |
| Coefficient Of Variation | (37.00) | |
| Mean Deviation | 18.45 | |
| Median | (44.44) | |
| Standard Deviation | 21.28 | |
| Sample Variance | 452.65 | |
| Range | 55.7114 | |
| R-Value | (0.80) | |
| Mean Square Error | 171.75 | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | (3.38) | |
| Total Sum of Squares | 7,242 |
Pulse Operating Margin History
About Pulse Biosciences Financial Statements
Pulse Biosciences stakeholders use historical fundamental indicators, such as Pulse Biosciences' Operating Margin, to determine how well the company is positioned to perform in the future. Although Pulse Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pulse Biosciences' assets and liabilities are reflected in the revenues and expenses on Pulse Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pulse Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. Pulse Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 142 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pulse Biosciences is a strong investment it is important to analyze Pulse Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulse Biosciences' future performance. For an informed investment choice regarding Pulse Stock, refer to the following important reports:Check out the analysis of Pulse Biosciences Correlation against competitors. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could Pulse diversify its offerings? Factors like these will boost the valuation of Pulse Biosciences. Anticipated expansion of Pulse directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulse Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Pulse Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Pulse Biosciences' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Pulse Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Pulse Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulse Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Pulse Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.